Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of CTNNAL1 mRNA | affects expression | 21346803
|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of CTNNAL1 mRNA | affects expression | 21346803
|
D002330 |
Carmustine |
Carmustine results in increased expression of CTNNAL1 mRNA | increases expression | 15980968
|
D016572 |
Cyclosporine |
Cyclosporine results in increased expression of CTNNAL1 mRNA | increases expression | 20106945
|
D002945 |
Cisplatin |
CTNNAL1 protein affects the susceptibility to Cisplatin | affects response to substance | 16217747
|
D004041 |
Dietary Fats |
Dietary Fats results in increased expression of CTNNAL1 mRNA | increases expression | 18042831
|
C011890 |
kojic acid |
kojic acid results in decreased expression of CTNNAL1 mRNA | decreases expression | 16595896
|
D015735 |
Mifepristone |
Mifepristone results in increased expression of CTNNAL1 mRNA | increases expression | 17584828
|
C041786 |
palm oil |
palm oil results in increased expression of CTNNAL1 mRNA | increases expression | 18042831
|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of CTNNAL1 mRNA | increases expression | 18301758
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D058186 |
Acute Kidney Injury |
|
Cisplatin |
4.13 | 17670903 15814532 12690470 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.30 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Cisplatin |
2.79 | 17638652 11798837 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
3.72 | 16434500 |
MESH:D001161 |
Arteriosclerosis |
|
Dietary Fats |
4.10 | 15238619 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
3.32 | 19483382 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Cisplatin |
5.15 | 14601052 |
MESH:D001932 |
Brain Neoplasms |
|
Carmustine |
4.55 | 16187019 |
MESH:D001943 |
Breast Neoplasms |
|
Cisplatin |
2.37 | 18382427 19526202 |
MESH:D001943 |
Breast Neoplasms |
|
Dietary Fats |
2.37 | 20435547 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
4.78 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
4.78 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Cisplatin |
4.78 | 17982673 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
Cisplatin |
3.09 | 12023789 16685392 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Cisplatin |
2.86 | 17066447 18337622 6189445 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
6.96 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
6.96 | 12371664 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
8.18 | 19486331 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
8.18 | 19176532 |
MESH:D015179 |
Colorectal Neoplasms |
|
Cisplatin |
2.33 | 15273666 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
11.63 | 18551238 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
11.63 | 18551238 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.49 | 18249437 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
4.00 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
4.00 | 18551238 21346803 |
MESH:D004362 |
Drug Toxicity |
|
Cisplatin |
3.98 | 12649298 12231392 15033597 19839026 |
MESH:D050171 |
Dyslipidemias |
|
Dietary Fats |
3.57 | 18367378 |
MESH:D004487 |
Edema |
|
pirinixic acid |
2.65 | 12083418 |
MESH:D004715 |
Endometriosis |
|
Mifepristone |
4.53 | 16134523 |
MESH:D004938 |
Esophageal Neoplasms |
|
Cisplatin |
2.81 | 16481741 15173087 17638652 15464296 16785472 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
14.08 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Dietary Fats |
14.08 | 17967931 19004024 19551842 18296743 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
14.08 | 19236843 20131406 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
9.42 | 12639820 12168785 |
MESH:D005355 |
Fibrosis |
|
Dietary Fats |
9.42 | 18296743 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.46 | 8708960 |
MESH:D005909 |
Glioblastoma |
|
Carmustine |
4.03 | 16187019 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Cisplatin |
3.82 | 15464296 15102660 |
MESH:D034381 |
Hearing Loss |
|
Cisplatin |
4.45 | 19898482 |
MESH:D006319 |
Hearing Loss, Sensorineural |
|
Cisplatin |
4.56 | 15464296 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.63 | 20558911 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.66 | 15720958 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
3.21 | 16221962 19176532 19772884 18467677 |
MESH:D006689 |
Hodgkin Disease |
|
Cisplatin |
3.74 | 16170182 16200630 |
MESH:D006937 |
Hypercholesterolemia |
|
Dietary Fats |
3.76 | 21332399 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.34 | 20558911 |
MESH:D006949 |
Hyperlipidemias |
|
Dietary Fats |
3.80 | 21332399 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
2.15 | 10903974 |
MESH:D007249 |
Inflammation |
|
Dietary Fats |
2.51 | 20412841 |
MESH:D007333 |
Insulin Resistance |
|
Dietary Fats |
7.61 | 11836018 18457598 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
7.61 | 16306350 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.71 | 15604871 |
MESH:D007673 |
Kidney Cortex Necrosis |
|
Cisplatin |
5.41 | 15464296 |
MESH:D007674 |
Kidney Diseases |
|
Cisplatin |
6.49 | 18289764 12649298 12231392 15190930 19839026 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
6.49 | 8314463 10903974 18776723 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
13.22 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
13.22 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
13.22 | 12371664 |
MESH:D007683 |
Kidney Tubular Necrosis, Acute |
|
Cisplatin |
5.06 | 11231351 |
MESH:D008103 |
Liver Cirrhosis |
|
Dietary Fats |
2.96 | 18296743 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
1.34 | 15474484 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
4.60 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
4.60 | 15890375 20007298 16377806 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
6.52 | 6135515 2876784 2876786 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
kojic acid |
6.52 | 18544905 |
MESH:D008175 |
Lung Neoplasms |
|
Cisplatin |
2.33 | 17225452 11798837 6189445 |
MESH:D008545 |
Melanoma |
|
Carmustine |
3.92 | 12393984 |
MESH:D008545 |
Melanoma |
|
Cisplatin |
3.92 | 17761969 18505091 12883367 16809738 16432458 18176117 17023156 11135225 18332650 12374674 15577323 12393984 16248763 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Cisplatin |
5.01 | 15990972 |
MESH:D008654 |
Mesothelioma |
|
Cisplatin |
3.30 | 17638057 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
5.05 | 16801185 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.72 | 16239165 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.20 | 19151258 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
3.08 | 16411023 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
11.15 | 18551238 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
11.15 | 18551238 7678174 |
MESH:D009369 |
Neoplasms |
|
Cisplatin |
5.36 | 16773208 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
5.36 | 17405874 |
MESH:D009395 |
Nephritis, Interstitial |
|
Cisplatin |
4.76 | 15464296 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.71 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.44 | 18481113 19348381 |
MESH:D009447 |
Neuroblastoma |
|
Cisplatin |
3.53 | 8761367 |
MESH:D017599 |
Neuroectodermal Tumors |
|
Cisplatin |
4.93 | 8761367 |
MESH:D009765 |
Obesity |
|
Dietary Fats |
4.56 | 21332399 11836018 20518802 18674790 17217161 18457598 16723640 19632207 20132043 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
4.56 | 20558911 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
9.43 | 12819281 16049721 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
9.43 | 16049721 |
MESH:D010051 |
Ovarian Neoplasms |
|
Cisplatin |
5.49 | 15464296 19769630 6897625 17225452 |
MESH:D010051 |
Ovarian Neoplasms |
|
Mifepristone |
5.49 | 16525653 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Cisplatin |
3.04 | 19003803 |
MESH:D010523 |
Peripheral Nervous System Diseases |
|
Cisplatin |
4.51 | 15464296 |
MESH:D010997 |
Pleural Neoplasms |
|
Cisplatin |
5.61 | 17638057 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.37 | 12371664 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.28 | 16882103 |
MESH:D051437 |
Renal Insufficiency |
|
Cisplatin |
4.62 | 15464296 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.46 | 19058328 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Cisplatin |
4.63 | 14601052 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
6.25 | 18551238 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
6.25 | 18551238 |
MESH:D055752 |
Small Cell Lung Carcinoma |
|
Cisplatin |
5.61 | 15464296 |
MESH:D013274 |
Stomach Neoplasms |
|
Cisplatin |
2.33 | 15958060 17522103 18396642 |
MESH:D013736 |
Testicular Neoplasms |
|
Cisplatin |
4.81 | 17225452 15464296 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
8.72 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
8.72 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Cisplatin |
8.72 | 12973940 17225452 15464296 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
12.80 | 10091137 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
12.80 | 10091137 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Cisplatin |
4.37 | 16803524 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.25 | 1336536 |
MESH:D014625 |
Vaginal Neoplasms |
|
Cisplatin |
4.82 | 15577323 |
MESH:D014839 |
Vomiting |
|
Cisplatin |
4.98 | 11897121 |
MESH:D015430 |
Weight Gain |
|
Dietary Fats |
3.89 | 16723640 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.71 | 17120751 |